S&P 500, Dow futures rise before big bank earnings and CPI data

Reuters | October 14, 2026 at 10:13 AM UTC
Neutral 87% Confidence Majority Agreement
Read Original Article

Key Points

  • Economists expect headline inflation to accelerate to 3.6% annually in September, with investors pricing in a 22% chance of another Fed rate hike
  • Chip stocks traded mixed following concerns about China's CXMT chip design progress, with Intel and Micron down while Nvidia gained slightly
  • Oil prices remained elevated above $100 per barrel after two vessels were struck in the Strait of Hormuz, with Iran reportedly deploying new tactics to target ships

AI Summary

Market Summary: S&P 500 and Dow Futures Rise Ahead of Key Data

Market Movement:

U.S. stock futures showed mixed performance on October 14, with Dow E-minis up 0.45% (234 points) and S&P 500 E-minis up 0.21% (16.25 points), while Nasdaq 100 E-minis fell 0.03% (9 points) as of 5:41 a.m. ET.

Key Drivers:

Investors await critical September CPI data, with economists projecting headline inflation at 3.6% annually and core CPI rising 0.2% monthly. Markets are pricing in a 22% probability of a quarter-point rate hike next week, according to the CME FedWatch Tool.

Banking Sector:

Major financial institutions reporting earnings include Bank of America, Morgan Stanley, BlackRock, and State Street, following mixed results from earlier reports.

Technology Sector:

AI and chip stocks showed volatility after concerns over Chinese chipmaker CXMT's design progress intensified competition worries. Intel and Micron declined 1.1% and 1.3% respectively, while Nvidia gained 0.2%. The "Magnificent Seven" stocks generally rose, with Alphabet up 0.7% and Meta and Amazon marginally higher.

Energy Markets:

Oil prices remain elevated, with Brent crude above $100 per barrel following attacks on two vessels in the Strait of Hormuz, with Iranian officials reportedly deploying new tactics against ships.

Notable Movers:

Liquidia surged 49.9% after settling six lawsuits with United Therapeutics, securing uninterrupted access to its pulmonary hypertension drug Yutrepia.

Fed Commentary:

New York Fed President John Williams indicated potential for one more rate hike in the current year but sees no need for increases in 2027. Additional remarks from Richmond Fed President Tom Barkin and the Fed's Beige Book are expected later.

Model Analysis Breakdown

Model Sentiment Confidence
GPT-5-mini Neutral 82%
Claude 4.5 Haiku Neutral 85%
Gemini 2.5 Flash Bullish 95%
Consensus Neutral 87%